Value Based Healthcare in Psoriasis

NARecruitingINTERVENTIONAL
Enrollment

350

Participants

Timeline

Start Date

March 1, 2023

Primary Completion Date

March 1, 2025

Study Completion Date

September 1, 2025

Conditions
Psoriasis
Interventions
OTHER

Patients receiving PsoPlus care

As stated before, both outcomes (via VOS) and costs will be collected. Data on clinical outcomes, such as skin clearance, in the VOS will be collected during follow-up visits at our clinic. Outcomes which are assessed via a questionnaire will be collected using a specialized patient platform (PsoQuest). In addition, for this study the EuroQol 5 Dimensions 5 Level (EQ-5D-5L) questionnaire will need to be filled in. When consultations do not coincide with the time points, data will be collected by a study nurse on a study visit (at our department or the patient's home) and via PsoQuest. A 1 month period will be in place around the time point, meaning that the data can be collected 2 weeks beforehand or afterwards. Cost data will be collected using the TD-ABC approach over the full cycle of care.

Trial Locations (2)

9000

NOT_YET_RECRUITING

University Hospital Ghent, Ghent

RECRUITING

University Hospital Ghent, Ghent

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Janssen, LP

INDUSTRY

collaborator

Vlerick Business School

UNKNOWN

collaborator

Scientific Research Foundation-Flanders

UNKNOWN

lead

University Hospital, Ghent

OTHER